Literature DB >> 27221597

Visual Perceptual Organization Ability in Autopsy-Verified Dementia with Lewy Bodies and Alzheimer's Disease.

Micaela Mitolo1, Joanne M Hamilton2, Kelly M Landy2, Lawrence A Hansen2, Douglas Galasko2, Francesca Pazzaglia3, David P Salmon2.   

Abstract

OBJECTIVES: Prominent impairment of visuospatial processing is a feature of dementia with Lewy bodies (DLB), and diagnosis of this impairment may help clinically distinguish DLB from Alzheimer's disease (AD). The current study compared autopsy-confirmed DLB and AD patients on the Hooper Visual Organization Test (VOT), a test that requires perceptual and mental reorganization of parts of an object into an identifiable whole. The VOT may be particularly sensitive to DLB since it involves integration of visual information processed in separate dorsal and ventral visual "streams".
METHODS: Demographically similar DLB (n=28), AD (n=115), and normal control (NC; n=85) participants were compared on the VOT and additional neuropsychological tests. Patient groups did not differ in dementia severity at time of VOT testing. High and Low AD-Braak stage DLB subgroups were compared to examine the influence of concomitant AD pathology on VOT performance.
RESULTS: Both patient groups were impaired compared to NC participants. VOT scores of DLB patients were significantly lower than those of AD patients. The diagnostic sensitivity and specificity of the VOT for patients versus controls was good, but marginal for DLB versus AD. High-Braak and low-Braak DLB patients did not differ on the VOT, but High-Braak DLB performed worse than Low-Braak DLB on tests of episodic memory and language.
CONCLUSIONS: Visual perceptual organization ability is more impaired in DLB than AD but not strongly diagnostic. The disproportionate severity of this visual perceptual deficit in DLB is not related to degree of concomitant AD pathology, which suggests that it might primarily reflect Lewy body pathology. (JINS, 2016, 22, 609-619).

Entities:  

Keywords:  Alzheimer’s disease; Dementia; Dementia with Lewy Bodies; Visual organization; Visuoperceptual deficit; Visuospatial deficit

Mesh:

Year:  2016        PMID: 27221597      PMCID: PMC5802394          DOI: 10.1017/S1355617716000436

Source DB:  PubMed          Journal:  J Int Neuropsychol Soc        ISSN: 1355-6177            Impact factor:   2.892


  70 in total

1.  Pentagon copying is more impaired in dementia with Lewy bodies than in Alzheimer's disease.

Authors:  T A Ala; L F Hughes; G A Kyrouac; M W Ghobrial; R J Elble
Journal:  J Neurol Neurosurg Psychiatry       Date:  2001-04       Impact factor: 10.154

2.  Factor structure of the Hooper Visual Organization Test: a cross-cultural replication and extension.

Authors:  Thomas Merten
Journal:  Arch Clin Neuropsychol       Date:  2005-01       Impact factor: 2.813

3.  Clock-face drawing to differentiate Lewy body and Alzheimer type dementia syndromes.

Authors:  K K Gnanalingham; E J Byrne; A Thornton
Journal:  Lancet       Date:  1996-03-09       Impact factor: 79.321

4.  Abnormal, ubiquitinated cortical neurites in patients with diffuse Lewy body disease.

Authors:  A Pellisé; C Roig; L I Barraquer-Bordás; I Ferrer
Journal:  Neurosci Lett       Date:  1996-03-15       Impact factor: 3.046

5.  Verbal and visuospatial deficits in dementia with Lewy bodies.

Authors:  David K Johnson; John C Morris; James E Galvin
Journal:  Neurology       Date:  2005-10-25       Impact factor: 9.910

6.  Cognitive differences in dementia patients with autopsy-verified AD, Lewy body pathology, or both.

Authors:  M L Kraybill; E B Larson; D W Tsuang; L Teri; W C McCormick; J D Bowen; W A Kukull; J B Leverenz; M M Cherrier
Journal:  Neurology       Date:  2005-06-28       Impact factor: 9.910

7.  Position paper on diagnostic criteria for Alzheimer disease.

Authors:  L A Hansen; R D Terry
Journal:  Neurobiol Aging       Date:  1997 Jul-Aug       Impact factor: 4.673

8.  Clinical and neuropathological findings in Lewy body dementias.

Authors:  D Galasko; R Katzman; D P Salmon; L Hansen
Journal:  Brain Cogn       Date:  1996-07       Impact factor: 2.310

9.  Amyloid β deposition, neurodegeneration, and cognitive decline in sporadic Alzheimer's disease: a prospective cohort study.

Authors:  Victor L Villemagne; Samantha Burnham; Pierrick Bourgeat; Belinda Brown; Kathryn A Ellis; Olivier Salvado; Cassandra Szoeke; S Lance Macaulay; Ralph Martins; Paul Maruff; David Ames; Christopher C Rowe; Colin L Masters
Journal:  Lancet Neurol       Date:  2013-03-08       Impact factor: 44.182

10.  Comparison of dementia with Lewy bodies to Alzheimer's disease and Parkinson's disease with dementia.

Authors:  Enrique Noe; Karen Marder; Karen L Bell; Diane M Jacobs; Jennifer J Manly; Yaakov Stern
Journal:  Mov Disord       Date:  2004-01       Impact factor: 10.338

View more
  6 in total

1.  Associations among Braak stage, Parkinsonian gait, cognition, and functional status in autopsy-confirmed dementia with Lewy bodies.

Authors:  Ann M Mayo; Guerry M Peavy
Journal:  Int J Geriatr Psychiatry       Date:  2019-03-15       Impact factor: 3.485

2.  Afferent and Efferent Visual Markers of Alzheimer's Disease: A Review and Update in Early Stage Disease.

Authors:  Shirley Z Wu; Arjun V Masurkar; Laura J Balcer
Journal:  Front Aging Neurosci       Date:  2020-09-11       Impact factor: 5.750

3.  Cognition at Each Stage of Lewy Body Disease with Co-occurring Alzheimer's Disease Pathology.

Authors:  Sephira G Ryman; Maya Yutsis; Lu Tian; Victor W Henderson; Thomas J Montine; David P Salmon; Douglas Galasko; Kathleen L Poston
Journal:  J Alzheimers Dis       Date:  2021       Impact factor: 4.472

4.  The gesture imitation test in dementia with Lewy bodies and Alzheimer's disease dementia.

Authors:  Xudong Li; Miaoxin Shen; Ziling Han; Jinsong Jiao; Xiaopeng Tong
Journal:  Front Neurol       Date:  2022-07-29       Impact factor: 4.086

5.  Chinese expert consensus on assessment of cognitive impairment in the elderly.

Authors:  Xiushi Ni; Fang Wu; Juan Song; Lina An; Qianwen Jiang; Tingting Bai; Jianye Wang; Pulin Yu; Cuntai Zhang; Jinhui Wu
Journal:  Aging Med (Milton)       Date:  2022-10-03

6.  Genome-Wide Profiling of miRNA and mRNA Expression in Alzheimer's Disease.

Authors:  Wan-Sheng Chang; Yong-Hong Wang; Xiao-Tun Zhu; Chuan-Jie Wu
Journal:  Med Sci Monit       Date:  2017-06-04
  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.